For Clinical Genetics Labs

Offer to your patients the latest PRS for clinical-grade risk prediction. Upload your SNP array or NGS data and our software performs PRS analysis in a cloud architecture that is fully automated, GDPR-HIPAA complaint and certified as a Medical Device. Differentiate your clinic from the crowd, embrace data-driven Preventive Healthcare.

For Researchers

You’re just two clicks away from your next PRS paper. Use our platform to perform the entire PRS pipeline, QC and imputation, without write a single line of code. Run and compare the performances of the most cited PRS methods, such as LD-Pred and Clumping and Thresholding. Focus only on what really matter for your research project. Just forget all the informatics hassles.

For Pharmas

Stratify participants of your clinical trials according to their genomic diversity. Identifying high risk individuals allows your Company to save money and time while having a better trial outcome. A simple genotyping array unlocks precious information on your cohort, invaluable in follow up decision-making in the modern area of drug development.

Trusted Translational Genomics

Allelica has built the first cloud platform that allows you to perform Polygenic Risk Score (PRS) analysis without writing a single line of code. The cloud architecture is a secure and trusted environment that has been certified as a Medical Device and is GDPR and HIPAA complaint. We work with leading clinical genetics labs, pharmaceutical companies and research institutes to improve health care prevention for a large number of complex diseases. The cloud platform accepts as input genotyping array and NGS data, performs genomic prediction analysis with published PRS or with your newly developed PRS.

Validation and testing on the UKBiobank is performed with just two clicks.

Why to Choose Allelica

Made by Scientist

Allelica DNA tests and algorithms have been developed thanks to a collaboration between researchers of the University of Oxford and the University of Rome “La Sapienza”.

Software as a Service
Use our SaaS for easy and fast data analysis and report. Use our pipelines to safely scale your genomic anaysis.
Privacy and Security
We give absolute priority to the privacy of your data. The genetic data are encoded through a secure protocol and encrypted in a single tenant node.

Appeared on


The Latest from Genomicriskscore

At the “ESC 2019 together with World Congress of Cardiology”, held in Paris in the first week of September, Allelica presented the newly developed software to compute Polygenic Risk Score (PRS) for Coronary Artery Disease. The clinical value of integrating PRS in traditional risk models was also discussed.


Come to meet us in Houston, Texas, at the annual conference of the American Society of Human Genetics, the largest and most exciting human genetic conference in the world. See you at booth #200 from the 15th to the 19th of October. The meeting provides a forum for the presentation and discussion of cutting-edge science in all areas of human genetics.

What we do

One Easy tool to predict complex disease

Perform Risk Prediction Analysis

Use the Allelica in Cloud software to perform Polygenic Risk Score Analysis in a fast and safe way.


Preventive Healthcare

Provide the latest and most predictive Polygenic Risk Score for complex diseases published on high impact factor journals.

Cumulative  risk of Breast Cancer (BC) in UK Biobank female stratified by different percentiles of the Polygenic Risk Score (PRS)
Prevalence gradient for Breast Cancer (BC) across the distribution of the Polygenic Risk Score in UK Biobank population. Each point represents a different percentile of the PRS distribution.
Cumulative risk of Coronary Artery Disease (CAD) in UK Biobank population by different percentiles of the Polygenic Risk Score (PRS).
Prevalence gradient for Coronary Artery Disease (CAD) across the distribution of the Polygenic Risk Score in UK Biobank population. Each point represents a different percentile of the PRS distribution.
Bar chart showing the association between Polygenic Risk Scores (PRS) quintiles (third and fifth), Body Mass Index (BMI), and the risk of developing of Type 2 Diabetes (T2D).
Prevalence gradient for Type 2 Diabetes (T2D) across the distribution of the Polygenic Risk Score in UK Biobank population. Each point represents a different percentile of the PRS distribution.

Allelica founders carried out research at the University of


Funded by

The European project for innovation in Health


The Seed Fund


The Italian Pree-Seed grant to support Research Spin-Off